{"version":"1.0","type":"link","title":"DSP502 combines dual inhibition of PD-L1 and PVR to trigger anti-cancer immune responses.","author_name":"Melo Gallegos VA 외","author_url":"https://prs-insight.online/author/Melo%20Gallegos%20VA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98333","thumbnail_width":1200,"thumbnail_height":630}